EphB2 Antibody (Rabbit mAb) [D9P3]

Catalog No.: F7141

    Application: Reactivity:
    • Lane 1: HCT116, Lane 2: HCT116 (KO EPHB2), Lane 3: Mouse brain, Lane 4: Rat brain
    1/
    サイズ 価格(税別) 在庫状況
    JPY 15400 国内在庫なし(納期7~10日)
    JPY 38400 国内在庫なし(納期7~10日)
    JPY 57700 お問い合わせ

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp
    よく尋ねられる質問

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000 - 1:5000
    1:1000
    Application
    WB, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    117 kDa 130 kDa, 27 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Rat colon tissue; Rat liver tissue; Human bladder cancer tissue; Human brain tissue; Human colon tissue; Human small intestine tissue; Mouse brain tissue; Rat brain tissue; Rat stomach tissue; Mouse colon tissue; Mouse liver tissue; HCT 116 cells; A549 cells; HepG2 cells; HT-1080 cells; NIH/3T3 cells; 4T1 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    EphB2 Antibody (Rabbit mAb) [D9P3] detects endogenous levels of total EphB2 protein.
    タンパク質の局在
    細胞膜、細胞突起、細胞内膜系
    Uniprot ID
    P29323
    Clone
    D9P3
    Synonym(s)
    DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5, EPHB2, Ephrin type-B receptor 2, EK5, hEK5
    Background
    Eph receptor B2 (EphB2) is a transmembrane receptor tyrosine kinase of the EphB subfamily that recognizes membrane‑anchored ephrin‑B ligands, primarily ephrin‑B2 and ephrin‑B3, to mediate contact‑dependent bidirectional signaling that organizes cell positioning, boundary formation, axon guidance, vascular patterning, and tissue remodeling in development and disease. The receptor ectodomain comprises a ligand‑binding domain, a cysteine‑rich region, and two fibronectin type III repeats, followed by a single transmembrane helix and an intracellular segment with a juxtamembrane regulatory region, a tyrosine kinase domain, a sterile‑α‑motif (SAM) domain, and a PDZ‑binding motif; recent crystallography of the full ectodomain shows that EphB2 forms homotypic head‑to‑tail interactions between its ligand‑binding and fibronectin domains that create autoinhibitory receptor–receptor assemblies, with ephrin binding and post‑translational modifications modulating this arrangement to permit higher‑order clustering required for robust downstream signaling. Ligand engagement at sites of cell–cell contact induces EphB2 clustering, activation‑loop phosphorylation, and recruitment of SH2/SH3‑containing effectors including Src‑family kinases, p120RasGAP, Nck, and focal adhesion kinase; through these complexes EphB2 regulates small GTPases of the Rho and Ras families and can either repress or stabilize Ras–ERK MAPK signaling depending on the composition of its phosphotyrosine motifs and SH2 docking sites, such that engineered alterations in RasGAP versus Grb2 binding within EphB2 shift ERK output and correlate with neurite retraction versus extension, linking MAPK regulation directly to growth cone collapse and axon guidance decisions. EphB2 forward signaling also intersects with PI3K–Akt, JNK, and Src–FAK pathways to modulate cytoskeletal dynamics, adhesion complex turnover, and cell migration, while ephrin‑B reverse signaling through its own cytoplasmic tail and PDZ‑protein interactions coordinates complementary responses in the ligand‑expressing cell, creating a bidirectional code that governs cell sorting, boundary sharpening, and morphogenetic movements in the nervous and vascular systems. In the adult brain, EphB2 is enriched at excitatory synapses where it forms complexes with NMDA receptors and scaffolding proteins, potentiates synaptic NMDAR function, and regulates spine morphogenesis and synaptic plasticity, and restoration of EphB2 expression in an Alzheimer’s disease mouse model rescues NMDAR‑dependent long‑term potentiation and spatial memory, implicating loss of EphB2‑NMDAR signaling as a contributing mechanism in cognitive decline. In cancer, EphB2 expression is frequently dysregulated and exerts context‑dependent tumor‑promoting or tumor‑suppressive functions: elevated EphB2 is reported in colorectal, gastric, hepatic, and breast carcinomas, where it can enhance proliferation, survival, autophagy, invasion, and epithelial–mesenchymal transition through sustained activation of oncogenic pathways and remodeling of the tumor microenvironment, yet in certain settings compartmentalized EphB2 signaling at tumor–stroma boundaries restricts cell intermingling and may suppress early tumor expansion, reflecting the dualistic nature of Eph receptor signaling. EphB2 is also upregulated in fibrotic liver and kidney, where it promotes activation of hepatic stellate cells and myofibroblast differentiation and contributes to deposition of extracellular matrix, positioning EphB2 as a driver of organ fibrosis and a candidate therapeutic target in chronic liver and kidney disease.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください